Post-Conference Perspectives: Recent Advances in the Management of Chronic GvHD - Episode 1

The Chronic GvHD Landscape: Risk Factors and Diagnosis

,

Preet M. Chaudhary, MD, PhD and Noah Merin, MD, PhD review how chronic GvHD is diagnosed, the different types of chronic GvHD, and key risk factors for the disease.

Now Viewing
EP. 1: The Chronic GvHD Landscape: Risk Factors and Diagnosis
EP. 2: First-line Treatment for Patients with Chronic GvHD
EP. 3: Defining and Managing Steroid Refractory Chronic GvHD
EP. 4: Role of Ruxolitinib in Steroid-Refractory Chronic GvHD
EP. 5: Understanding Mechanisms of Action: Ruxolitinib, Ibrutinib, and Belumosudil
EP. 6: Key Efficacy Data of Ibrutinib and Belumosudil in Steroid-Refractory Chronic GvHD Patients
EP. 7: Real World Data on the Use of Ruxolitinib and Treatment Selection in chronic GvHD
EP. 8: Future Directions in Chronic GvHD